Evidence map›Paper›PMID 38865666›Full record

ArticleThe New England journal of medicine2024

Near-Universal Resistance to Macrolides of

Nicole A P Lieberman, Tara B Reid, Chase A Cannon, B Ethan Nunley, Anna Berzkalns, Stephanie E Cohen, Lori M Newman, Sol Aldrete, Linda H Xu, Clinton P Thornlund and 17 more

Abstract readLetter
In one paragraph

Article in The New England journal of medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Trial
  2. Putative mechanisms of ocular inflammation in syphilis.Journal of ophthalmic inflammation and infection · 2026
    Review
  3. Key Considerations in Evaluating Syphilis Therapeutics.Sexually transmitted diseases · 2026
    Article
  4. The Global Syphilis Epidemic: Turning the Tide.Sexually transmitted diseases · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Establishment of the Nichols strain as the type strain ofInternational journal of systematic and evolutionary microbiology · 2025
    Review
  12. Review
  13. Participants inFrontiers in immunology · 2025
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors.

Nicole A P LiebermanUniversity of Washington, Seattle, WA naliebe@uw.edu.ORCID 0000-0001-9334-8150
Tara B ReidUniversity of Washington, Seattle, WA naliebe@uw.edu.
Chase A CannonUniversity of Washington, Seattle, WA naliebe@uw.edu.ORCID 0000-0002-2962-754X
B Ethan NunleyUniversity of Washington, Seattle, WA naliebe@uw.edu.
Anna BerzkalnsPublic Health - Seattle and King County, Seattle, WA.
Stephanie E CohenSan Francisco Department of Public Health, San Francisco, CA.
Lori M NewmanNational Institutes of Health, Rockville, MD.
Sol AldreteMedical College of Wisconsin, Milwaukee, WI.
Linda H XuUniversity of Washington, Seattle, WA.
Clinton P ThornlundUniversity of Washington, Seattle, WA.
Kevin PettusCenters for Disease Control and Prevention, Atlanta, GA.
Stephanie LundyCenters for Disease Control and Prevention, Atlanta, GA.
Michael KronMedical College of Wisconsin, Milwaukee, WI.
Olusegun O SogeUniversity of Washington, Seattle, WA.
Kimberly WorkowskiEmory University, Atlanta, GA.
Charlotte PerlowskiFHI 360, Durham, NC.
Edward W HookUniversity of Alabama at Birmingham, Birmingham, AL.
Jodie A DionneUniversity of Alabama at Birmingham, Birmingham, AL.
Matthew R GoldenUniversity of Washington, Seattle, WA.
Joshua A LiebermanUniversity of Washington, Seattle, WA.
Min-Kuang LeeBritish Columbia Centre for Disease Control Public Health Laboratory, Vancouver, BC, Canada.
Muhammad MorshedBritish Columbia Centre for Disease Control Public Health Laboratory, Vancouver, BC, Canada.
Prenilla NaiduAlberta Precision Laboratories, Edmonton, AB, Canada.
Weiping CaoCenters for Disease Control and Prevention, Atlanta, GA.
Allan PillayCenters for Disease Control and Prevention, Atlanta, GA.
Lorenzo GiacaniUniversity of Washington, Seattle, WA.
Alexander L GreningerUniversity of Washington, Seattle, WA.

Funding

Leadership Group for the Infectious Diseases Clinical Research Consortium (IDCRCLG) - Momi-Vax DMID #21-0004 {Supplement #6}UM1AI148684 · NIAID · EMORY UNIVERSITY · PI DAVID S STEPHENS · 2020 to 2026
$77.2M
VENEREAL DISEASET32AI007140 · NIAID · UNIVERSITY OF WASHINGTON · PI Julia Cook Dombrowski · 1985 to 2026
$19.4M
University of Washington (UW) Sexually Transmitted Infections (STI) Cooperative Research Center (CRC) - Syphilis Vaccine to Protect against Local and Disseminated T. pallidum InfectionU19AI144133 · NIAID · UNIVERSITY OF WASHINGTON · PI WALD, ANNA · 2019 to 2023
$10.6M
Evaluation of a Treponema pallidum transcription mediated amplification assay for Syphilis ScreeningR01AI155442 · NIAID · UNIVERSITY OF WASHINGTON · PI GOLDEN, MATTHEW R · 2021 to 2025
$3.4M
National Institute of Allergy and Infectious Diseases HHSN272201300012NIAID NIH HHS HHSN272201300012CNIAID NIH HHS HHSN272201300012INIAID NIH HHS R01 AI155442NIAID NIH HHS T32 AI007140NIAID NIH HHS U19 AI144133NIAID NIH HHS UM1 AI148684
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsAzithromycinDrug Resistance, BacterialMacrolidesSyphilisTreponema pallidumCanadaDoxycyclineHumansNorth AmericaPenicillin G BenzathineUnited StatesAnti-Bacterial AgentsAzithromycinDoxycyclineMacrolidesPenicillin G Benzathine

Identifiers

PMID38865666
PMCPMC11345850

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.